Cambridge Heart MTWA Could Stratify ICD Population Into High/Low Risk
This article was originally published in The Gray Sheet
Executive Summary
Trials of Cambridge Heart's Microvolt T-Wave Alternans (MTWA) test in patients with left ventricular dysfunction suggest that approximately one-third of patients indicated for an ICD under the MADIT-II criteria may not benefit from ICD therapy
You may also be interested in...
Cardiac Devices In Brief
Cypher in diabetics: Johnson & Johnson/Cordis' Cypher sirolimus-eluting coronary stent performs equally well in both insulin dependant and non-insulin dependent diabetics, according to 1,407-patient trial led by Ron Waksman, MD, Washington Hospital Center. Cypher linked to six-month target vessel revascularization rates of 8%, 7.9% and 6% in non-insulin dependant, insulin dependant and non-diabetic patients, respectively, according to study results presented Nov. 9 at the American Heart Association Annual Scientific Sessions in New Orleans. Study findings support results from the 160-patient Spanish DIABETES study presented at September TCT meeting in Washington, D.C. (1"The Gray Sheet" Oct. 4, 2004, p. 4)...
Cardiac Devices In Brief
Cypher in diabetics: Johnson & Johnson/Cordis' Cypher sirolimus-eluting coronary stent performs equally well in both insulin dependant and non-insulin dependent diabetics, according to 1,407-patient trial led by Ron Waksman, MD, Washington Hospital Center. Cypher linked to six-month target vessel revascularization rates of 8%, 7.9% and 6% in non-insulin dependant, insulin dependant and non-diabetic patients, respectively, according to study results presented Nov. 9 at the American Heart Association Annual Scientific Sessions in New Orleans. Study findings support results from the 160-patient Spanish DIABETES study presented at September TCT meeting in Washington, D.C. (1"The Gray Sheet" Oct. 4, 2004, p. 4)...
Johns Hopkins ICD Risk Stratification Studies Funded By Reynolds Foundation
Genomic and proteomic risk markers for sudden cardiac death will be evaluated over the next four years in a major ICD registry led by Johns Hopkins University researchers